GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Boston Scientific Corporation (BSX) [hlAlert]

Rating:
Buy BSX
up 143.04 %

Boston Scientific Corporation (BSX) rated Buy with price target $9 by Stifel Nicolaus

Posted on: Wednesday,  Feb 13, 2013  9:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Boston Scientific Corporation (NYSE: BSX) on 02/13/2013. Previously Stifel Nicolaus rated Buy Boston Scientific Corporation (NYSE: BSX) on
06/22/2011., when the stock price was $6.97. Since then, Boston Scientific Corporation has gained 143.04% as of 10/28/2015's recent price of $16.94.
If you would have followed the previous Stifel Nicolaus's recommendation on BSX, you would have gained 143.04% of your investment in 1589 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/13/2013 9:25 AM Buy
None
7.59 9.00
as of 12/13/2013
1 Week down  -3.88 %
1 Month down  -4.52 %
3 Months down  -3.80 %
1 YTD up  98.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2012 8:25 AM Buy
None
5.23 6.50
6/22/2011 8:25 AM Buy
None
6.97 9.00
9/2/2010 8:25 AM Hold
None
5.18

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy